Dr. Visha Rajagopalan receives $154,000 grant to study cardiovascular dysfunction
by February 22, 2024 10:39 pm 594 views
Dr. Vishwa Rajagopalan, professor of biomedical and anatomical sciences at New York Institute of Technology College of Osteopathic Medicine at Arkansas State University, has secured a two-year grant from the American Heart Association (AHA) to study cardiovascular dysfunction.
The funding, which totals $154,000, was awarded through the AHA’s Institutional Research Enhancement Award initiative, the association’s equivalent of the National Institutes of Health (NIH) R15 award.
“We are incredibly proud of Dr. Rajagopalan for receiving this well-deserved award,” said Shane Speights, dean of NYITCOM at A-State. “Cardiovascular disease is one of the leading causes of death in all Americans, but it is particularly prevalent in Arkansas and the Mississippi Delta region, which makes Dr. Rajagopalan’s work all the more important to the people who live in this part of the country.”
Rajagopalan’s research will focus on the role of noncoding ribonucleic acid (RNA), a molecule present in most living organisms and viruses, in cardiac dysfunction. He will study a specific gene to see if and how noncoding RNA may impact heart health.
“RNA-based treatment is becoming increasingly popular,” said Rajagopalan, who is also a fellow of the Cardiovascular Section of the American Physiology Society. “This study will investigate the importance of a key long noncoding RNA in mediating heart attacks associated with thyroid dysfunction. We hope to use this knowledge to improve heart function and, in turn, decrease cardiovascular-related death. The study will use a modified form of CRISPR and other exciting technologies to answer these questions.”
Rajagopalan conducts his research at the Arkansas Biosciences Institute on the Arkansas State University campus. Medical students from NYITCOM and biological sciences students at A-State will work with him on this project, gaining hands-on research experience. Junming Yue, associate professor at the University of Tennessee Health Sciences Center, will serve as a consultant.
Rajagopalan joined NYITCOM in 2012 and moved to Jonesboro in 2016 upon the opening of the school’s Arkansas location. He began his career at the Institute of Cardiovascular Diseases, where India’s heart transplant program was pioneered, and obtained comprehensive general and cardiothoracic clinical training and earned a degree from the Birla Institute of Technology and Science (BITS).
Following his tenure as a healthcare professional, Rajagopalan moved to the United States for advanced training in cardiovascular sciences. After completing his doctoral studies in molecular and translational aspects of physiology at the University of Nebraska Medical Center, he began postdoctoral work at the Stanford University Medical Center, which is known for groundbreaking contributions to human heart transplantation.
Throughout his time at NYITCOM, Rajagopalan has conducted extensive research on the impact of thyroid hormone on heart function and associated disorders.
“The work that Dr. Rajagopalan is doing is incredibly important, and we’re thrilled to see the AHA validate that through their support,” said Dosha Cummins chair of NYITCOM at A-State’s Department of Biomedical and Anatomical Sciences. “He is an invaluable member of our faculty and we’re very proud to join him in celebrating this award.”